Brain Fog Following COVID-19 (SARS-COV-2 Infection)
Brief description of study
The purpose of this study is to examine whether or not individuals who were previously diagnosed with SARS-CoV-2, or COVID-19, have greater cognitive and biomarker changes over five years than those individuals who did not have COVID-19.
This is a prospective, observational, longitudinal cohort study (n=300) of the following groups:
- SARS-CoV-2 laboratory positive subjects who have new objective or subjective cognitive abnormalities within 12 months of SARS-CoV-2 infection (COVID+Cog+);
- SARS-CoV-2 laboratory positive subjects without new cognitive findings within 12 months of SARS-CoV-2 infection (COVID+Cog-); or
- SARS-CoV-2 negative subjects who are cognitively normal (Controls).
Participants will be compensated $50 for travel expenses and an additional $75 for each completed MRI.
We are currently recruiting people who have never had a history of COVID-19 and who have never tested positive for SARS-CoV-2 or COVID-19.
Clinical Study Identifier: s22-00517
Principal Investigator:
Thomas M Wisniewski.
Other Investigators:
Arjun V. Masurkar,
Sujata P. Thawani,
Yulin Ge,
Allal Boutajangout,
Jennifer A. Frontera,
Laura J Balcer.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.